EUVIMEDEUVIMED entdecken
Crossref

Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer

Hyeong Jung Woo, Paul N Rademacher, Hyun Young Shin, Jungmin Lee, Aseer Intisar iD, Majid E Warkiani iD, Jae Young Joung, Alexey Rzhevskiy, Cornelia Coith, Frederike Harten, Felix Hilpert, Barbara Schmalfeldt und 4 weitere

Analytical Chemistry · 2025

DOI: 10.1021/acs.analchem.5c02154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2025. Verfasst von Hyeong Jung Woo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of New Biology, DGIST, Techno jungang-daero 333, Daegu 42988, Republic of Korea. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, Cell Separation, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: European Commission, Ministry of Science and ICT, South Korea, German Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Circulating tumor cells (CTCs) are a key biomarker in cancer diagnostics, offering critical insights into metastasis and treatment responses. Although several automated CTC isolation systems have been developed, a thorough comparison of their performance with diverse cell types remains lacking. In addition to CTCs, simultaneous tumor microenvironment (TME) analysis can be valuable for formulating cancer treatment strategies. This includes investigating circulating cancer-associated fibroblasts (cCAFs), which offer a minimally invasive, real-time status of the TME, enabling frequent monitoring of cancer metastasis and treatment response. However, the automated and simultaneous isolation of CTCs and cCAFs has been unexplored. This research systematically evaluated the performance of FDA-registered automated CTC isolation systems with cancer cells of heterogeneous phenotypes, a breast cancer CTC cell line, as well as clinical samples from 27 breast cancer patients. The continuous centrifugal microfluidic system (CTCeptor) demonstrated superior recovery rates and enriched CTCs with broader size and surface marker heterogeneity compared to other positive selection-based technologies, isolating significantly more CTCs from the blood of cancer patients and achieving high detection rates. Notably, since the system relies on an unbiased isolation method, it also isolated cCAFs from patient blood, which were detected at frequencies 10 times higher than CTCs in early-stage breast cancer patients. For the first time, this study identified key CAF markers, highlighting the potential of cCAFs as a biomarker for early diagnosis and prognosis. The ability of this automated system to efficiently isolate both CTCs and cCAFs represents a significant advancement in liquid biopsy and precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingBreast NeoplasmsCell SeparationCancer-Associated FibroblastsHumansLiquid BiopsyFemaleAutomationCell Line, Tumor

Autor:innen und Institutionen

  • Department of New Biology, DGIST, Techno jungang-daero 333, Daegu 42988, Republic of Korea.
  • Department of Tumor Biology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany.
  • CTCELLS Inc., Seoul 06307, Republic of Korea.
  • School of Biomedical Engineering, University of Technology Sydney, Sydney, New South Wales 2007, Australia.
  • National Cancer Center, Ilsan-ro 323, Goyang 10408, Republic of Korea.
  • Mammazentrum Hamburg at Jerusalem Hospital Hamburg, Schaeferkampsallee 34, 20357 Hamburg, Germany.

ORCID-Profile: Aseer Intisar, Majid E Warkiani, Minseok S Kim

Förderung

  • European Commission
  • Ministry of Science and ICT, South Korea
  • German Cancer Foundation

Zitieren

APA

Woo, H. J., Rademacher, P. N., Shin, H. Y., Lee, J., Intisar, A., Warkiani, M. E., Joung, J. Y., Rzhevskiy, A., Coith, C., Harten, F., Hilpert, F., Schmalfeldt, B., Riethdorf, S., Pantel, K., Joosse, S. A., & Kim, M. S. (2025). Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.5c02154

Vancouver

Woo HJ, Rademacher PN, Shin HY, Lee J, Intisar A, Warkiani ME, et al. Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer. Analytical Chemistry. 2025. doi:10.1021/acs.analchem.5c02154

BibTeX
@article{Woo2025,
  author = {Woo, Hyeong Jung and Rademacher, Paul N and Shin, Hyun Young and Lee, Jungmin and Intisar, Aseer and Warkiani, Majid E and Joung, Jae Young and Rzhevskiy, Alexey and Coith, Cornelia and Harten, Frederike and Hilpert, Felix and Schmalfeldt, Barbara and Riethdorf, Sabine and Pantel, Klaus and Joosse, Simon A and Kim, Minseok S},
  title = {Robust Automated Separation of Circulating Tumor Cells and Cancer-Associated Fibroblasts for Enhanced Liquid Biopsy in Breast Cancer},
  journal = {Analytical Chemistry},
  year = {2025},
  doi = {10.1021/acs.analchem.5c02154}
}
Kostenlos starten →